British Heart Rhythm Society Clinical Practice Guidelines on the Management of Patients Developing QT Prolongation on Antipsychotic Medication.

PD Lambiase; Bono JP de; RJ Schilling; M Lowe; A Turley; A Slade; J Collinson; K Rajappan; S Harris; J Collison; V Carpenter; H Daw; A Hall; D Taylor

doi:10.15420/aer.2019.8.3.G1

British Heart Rhythm Society Clinical Practice Guidelines on the Management of Patients Developing QT Prolongation on Antipsychotic Medication.

PD Lambiase, Bono JP de, RJ Schilling, M Lowe, A Turley, A Slade, J Collinson, K Rajappan, S Harris, J Collison, V Carpenter, H Daw, A Hall, D Taylor

Research output: Contribution to journal › Article › peer-review

22 Citations (Scopus)

Abstract

The British Heart Rhythm Society’s Clinical Practice Guidelines on the Management of Patients Developing QT Prolongation on Antipsychotic Medication are written for heart rhythm consultants, primary care physicians, specialist registrars, nurses and physiologists who may be requested to review ECGs or advise on cases where antipsychotic-induced QT prolongation is suspected or proven. The guidance is adapted from the latest Maudsley Prescribing Guidelines in Psychiatry, published in 2018.

Original language	English
Pages (from-to)	161-165
Journal	Arrhythmia & electrophysiology review
Volume	8
Issue number	3
DOIs	https://doi.org/10.15420/aer.2019.8.3.G1
Publication status	Published - 1 Jul 2019

Keywords

Antipsychotic medication
schizophrenia
QT prolongation
guidelines
psychiatry

Access to Document

10.15420/aer.2019.8.3.G1Licence: CC BY

Cite this

Lambiase, PD., de, B. JP., Schilling, RJ., Lowe, M., Turley, A., Slade, A., Collinson, J., Rajappan, K., Harris, S., Collison, J., Carpenter, V., Daw, H., Hall, A., & Taylor, D. (2019). British Heart Rhythm Society Clinical Practice Guidelines on the Management of Patients Developing QT Prolongation on Antipsychotic Medication. Arrhythmia & electrophysiology review, 8(3), 161-165. https://doi.org/10.15420/aer.2019.8.3.G1

Lambiase, PD, de, BJP, Schilling, RJ, Lowe, M, Turley, A, Slade, A, Collinson, J, Rajappan, K, Harris, S, Collison, J, Carpenter, V, Daw, H, Hall, A & Taylor, D 2019, 'British Heart Rhythm Society Clinical Practice Guidelines on the Management of Patients Developing QT Prolongation on Antipsychotic Medication.', Arrhythmia & electrophysiology review, vol. 8, no. 3, pp. 161-165. https://doi.org/10.15420/aer.2019.8.3.G1

@article{50a5d171c1f1488a98532748d849a19c,

title = "British Heart Rhythm Society Clinical Practice Guidelines on the Management of Patients Developing QT Prolongation on Antipsychotic Medication.",

abstract = "The British Heart Rhythm Society{\textquoteright}s Clinical Practice Guidelines on the Management of Patients Developing QT Prolongation on Antipsychotic Medication are written for heart rhythm consultants, primary care physicians, specialist registrars, nurses and physiologists who may be requested to review ECGs or advise on cases where antipsychotic-induced QT prolongation is suspected or proven. The guidance is adapted from the latest Maudsley Prescribing Guidelines in Psychiatry, published in 2018.",

keywords = "Antipsychotic medication, schizophrenia, QT prolongation, guidelines, psychiatry",

author = "PD Lambiase and de, {Bono JP} and RJ Schilling and M Lowe and A Turley and A Slade and J Collinson and K Rajappan and S Harris and J Collison and V Carpenter and H Daw and A Hall and D Taylor",

year = "2019",

month = jul,

day = "1",

doi = "10.15420/aer.2019.8.3.G1",

language = "English",

volume = "8",

pages = "161--165",

journal = "Arrhythmia & electrophysiology review",

number = "3",

}

TY - JOUR

T1 - British Heart Rhythm Society Clinical Practice Guidelines on the Management of Patients Developing QT Prolongation on Antipsychotic Medication.

AU - Lambiase, PD

AU - de, Bono JP

AU - Schilling, RJ

AU - Lowe, M

AU - Turley, A

AU - Slade, A

AU - Collinson, J

AU - Rajappan, K

AU - Harris, S

AU - Collison, J

AU - Carpenter, V

AU - Daw, H

AU - Hall, A

AU - Taylor, D

PY - 2019/7/1

Y1 - 2019/7/1

N2 - The British Heart Rhythm Society’s Clinical Practice Guidelines on the Management of Patients Developing QT Prolongation on Antipsychotic Medication are written for heart rhythm consultants, primary care physicians, specialist registrars, nurses and physiologists who may be requested to review ECGs or advise on cases where antipsychotic-induced QT prolongation is suspected or proven. The guidance is adapted from the latest Maudsley Prescribing Guidelines in Psychiatry, published in 2018.

AB - The British Heart Rhythm Society’s Clinical Practice Guidelines on the Management of Patients Developing QT Prolongation on Antipsychotic Medication are written for heart rhythm consultants, primary care physicians, specialist registrars, nurses and physiologists who may be requested to review ECGs or advise on cases where antipsychotic-induced QT prolongation is suspected or proven. The guidance is adapted from the latest Maudsley Prescribing Guidelines in Psychiatry, published in 2018.

KW - Antipsychotic medication

KW - schizophrenia

KW - QT prolongation

KW - guidelines

KW - psychiatry

UR - http://europepmc.org/abstract/med/31463053

U2 - 10.15420/aer.2019.8.3.G1

DO - 10.15420/aer.2019.8.3.G1

M3 - Article

C2 - 31463053

VL - 8

SP - 161

EP - 165

JO - Arrhythmia & electrophysiology review

JF - Arrhythmia & electrophysiology review

IS - 3

ER -

British Heart Rhythm Society Clinical Practice Guidelines on the Management of Patients Developing QT Prolongation on Antipsychotic Medication.

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this